Item 16. FORM 10-K SUMMARY

3K characters. Original on sec.gov · Markdown

Item 16. FORM 10-K SUMMARY

None.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


	THE CLOROX COMPANY

Date: August 7, 2026	By:	/s/ Linda Rendle
		Linda Rendle
		Chair and Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.


Signature	Title	Date
/s/ G. Boswell	Director	August 7, 2026
G. Boswell
/s/ S. B. Bratspies	Director	August 7, 2026
S. B. Bratspies
/s/ P. R. Breber	Director	August 7, 2026
P. R. Breber
/s/ J. Denman	Director	August 7, 2026
J. Denman
/s/ E. Lee	Director	August 7, 2026
E. Lee
/s/ A. D. D. Mackay	Director	August 7, 2026
A. D. D. Mackay
/s/ S. Plaines	Director	August 7, 2026
S. Plaines
/s/ M. J. Shattock	Director	August 7, 2026
M. J. Shattock
/s/ R. J. Weiner	Director	August 7, 2026
R. J. Weiner
/s/ C. J. Williams	Director	August 7, 2026
C. J. Williams
/s/ L. Rendle	Chair and Chief Executive Officer (Principal Executive Officer)	August 7, 2026
L. Rendle
/s/ L. Bellet	Executive Vice President – Chief Financial Officer (Principal Financial Officer)	August 7, 2026
L. Bellet
/s/ L. Peck	Vice President – Chief Accounting Officer and Corporate Controller (Principal Accounting Officer)	August 7, 2026
L. Peck

Previous: Item 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES